The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
APOLLON: A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC).
 
Yasutoshi Kuboki
Honoraria - Bayer; Lilly Japan; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Daiichi Sankyo; Incyte (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
Takeshi Kato
Honoraria - Bayer; Chugai Pharma; Lilly; Sanofi; Takeda; Yakult Honsha
Research Funding - Chugai Pharma
 
Yoshinori Kagawa
No Relationships to Disclose
 
Makio Gamoh
Honoraria - Bayer; Chugai Pharma; Merck; Nippon Kayaku; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical; Takeda
 
Hirofumi Yasui
No Relationships to Disclose
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Yoshito Komatsu
Honoraria - Bayer; Novartis; Pfizer
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Bayer; Chugai Pharma; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Hironaga Satake
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Masahiro Goto
No Relationships to Disclose
 
Hiroaki Tanioka
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Masahito Kotaka
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Akitaka Makiyama
No Relationships to Disclose
 
Tadamichi Denda
Research Funding - Boehringer Ingelheim (Inst); MSD (Inst); Sanofi (Inst)
 
Junpei Soeda
Employment - Takeda
 
Kazunori Shibuya
Employment - Takeda
 
Masaru Iwata
Employment - Millennium
 
Koji Oba
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Ono Pharmaceutical; Takeda
 
Kensei Yamaguchi
Honoraria - Chugai Pharma; Lilly; Merck; Taiho Pharmaceutical; Takeda